Soleus Capital, LLC's Form 4 filing
Parabilis Medicines, Inc. (PBLS) · filed Jun 29, 2026
- Accession no.
- 0001213900-26-072928
- Filed
- Jun 29, 2026, 10:41 AM ET
- Trade date
- Jun 11, 2026
- Filing delay
- 18 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market purchases total $10.0M. It was filed 18 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Soleus Capital, LLCCIK 0001786724 | 10% Owner |
| Soleus Capital Management, L.P.CIK 0001802630 | 10% Owner |
| Soleus Capital Master Fund, L.P.CIK 0001812275 | 10% Owner |
| Soleus Capital Group, LLCCIK 0001812276 | 10% Owner |
| Levy GuyCIK 0001812305 | 10% Owner |
| Soleus Private Equity GP III, LLCCIK 0001955973 | 10% Owner |
| Soleus Private Equity Fund III, L.P.CIK 0001955982 | 10% Owner |
| Soleus GP, LLCCIK 0002088814 | 10% Owner |
| Soleus PE GP III, LLCCIK 0002088815 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +375,000 | $20.00 | +$7,500,000 | 1,027,000 | Indirect | |
| Jun 11, 2026 | Common Stock, par value $0.0001 per share | PPurchaseAcquired | +125,000 | $20.00 | +$2,500,000 | 652,000 | Indirect | |
| Jun 11, 2026 | Common Stock, par value $0.0001 per share | CConversionAcquired | +527,070 | $9.48 | +$4,996,623.6 | 527,070 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Common Stock | CConversionDisposed | −527,070 | $0.00 | $0 | 0 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.